FDA Postmarket Guidance Hammers Home Positions On Foreign Trials, Real-World Evidence

 
• By Sarah Karlin-Smith
diverse group of people
FDA issued draft guidance on obtaining data on unrepresented populations postmarket • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews